Different Stages’ “The man of the people”reveals how easily authority can be built on confidence rather than evidence, and ...
Sanofi’s Teizeild approved in the EU for patients with stage 2 type 1 diabetes. Approval based on the TN-10 phase 2 study that demonstrated a significant delay of onset of stage ...
Sanofi's Teizeild approved in the EU for patients with stage 2 type 1 diabetes Approval based on the TN-10 phase 2 study that demonstrated a significant delay of onset of stage 3 T1D in stage 2 T1D ...
The European Commission has approved Sanofi’s Teizeild as the first disease-modifying therapy in the EU to delay the onset of stage 3 type 1 diabetes in adults and children with stage 2 T1D. Supported ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback